You are here: Home > Institute of Excellence (CPD) > CPD Events > Optometry Virtually Connected 2023

Optometry Virtually Connected 2023

Provider: OA National Provider

Contact: Optometry Australia OA Provider, [E] cpd@optometry.org.au, [P] 96688550

Registration: https://ovc.joyn-us.app/registration/new

Learning Objectives

  • Develop an understanding of the difference between machine learning and deep learning
  • Develop an understanding of the difference between AI and statistical analysis
  • Develop an appreciation of the range of factors limiting AI deployment in eye care
  • Understand how ocular surface diseases can arise from, and be exacerbated by, common lifestyle choices such as diet and cosmetics
  • Understand the role local indoor and external environmental exposures play in driving the development of ocular surface diseases
  • Gain knowledge to help patients optimise quality of life using evidence-based recommendations, to minimise impacts of lifestyle choices and mitigate ocular surface disease development and propagation
  • Review the cycle of inflammation associated with the ‘vicious circle of dry eye disease’
  • Appreciate diagnostic criteria for dry eye disease categorisation
  • Consider current topical and oral therapeutic management strategies that best combat the clinical signs observed
  • Review the pathophysiology of blepharitis and DED
  • Understand effective management strategies for DED and co-morbidities
  • Consider the correlation between effective treatment strategies and patient satisfaction and quality of life
  • Explain how climate variables and environmental conditions can affect ocular surface health and function
  • Apply consensus-based guidelines to protect the ocular surface during extreme climate events
  • Proactively manage populations which are at greater risk of ocular surface disease during extreme climate events
  • Review the features of the most complete daily disposable silicone hydrogel lens on the market and its benefits for patients
  • Understand the technology of Alcon’s PRECISION BALANCE 8|4 toric lens design
  • Identify patients with severe keratitis from dry eye disease
  • Choose the most appropriate treatment option for individual patients
  • Recall the key outcomes from the real-world PERSPECTIVE study
  • Describe the correct use of Ikervis in eligible patients, including the prescribing process
  • Gain a comprehensive overview of the myopia control treatments available in Australia, and how to pick the right treatment for your patient
  • Learn the expected efficacy of each treatment, how to gauge your patient’s treatment effect, and to identify when a patient might need to consider dual therapy
  • Explain the role of near work in myopia
  • Understand how the biometry changes during near work
  • Understand the varying opinions on binocular vision and accommodation errors in myopia
  • Understand how the relative peripheral spherical equivalent refraction nasally and temporally may impact upon the development of myopia
  • Understand how anatomical asymmetry in the retina in the nasal and temporal regions in terms of cone and ganglion cell density may impact upon the development of myopia
  • Assess and recognise signs of pathological myopia
  • Become familiar with the primary components in early ocular growth, the impact of such growth on refractive development as well as important clinical implications
  • Understand how integrated software systems can increase diagnostic confidence and clinical efficiency
  • Understand how integrated software systems can assist in patient education and understanding of their disease
  • Understand how Integrated software systems can promote collaborative care and support effective communication between professionals
  • Understand the responsibility of optometrists to deliver culturally safe practice
  • Identify key features of evidence-based models of eye care
  • Understand the technology and benefits of the Ultra Monthly lens family and how they will benefit patients to live better and see better
  • Describe the advances in contact lens technology, including drug delivery and smart lenses
  • Understand how contact lenses affect the binocular vision system
  • Appreciate the impact of different contact lens designs on the binocular vision system
  • Understand the benefits of ACUVUE Eye Inspired Innovations and how they link to patient experience and retention
  • Understand how tools like MyACUVUE can help optometry practices retain patients
  • Consider the levers that relate to patient retention in the contact lens category
  • Understand the visual optics and prescribing patterns necessary for successful prescribing of contact lenses for presbyopia
  • Recognise the modifiable and non modifiable risk factors for contact lens associated corneal infection
  • Design strategies for communicating healthy contact lens wear
  • Develop an understanding of how MiSight 1 day slowed the myopia of children progressing at different rates
  • Develop an understanding of how different measures can be used to fully understand treatment efficacy in myopia management
  • Identify the main types of systemic anticancer drugs used in medical oncology settings (chemotherapy, hormonal agents, targeted therapies)
  • Recognise ocular complications arising from treatment with anticancer drugs, and the appropriate management for these side effects
  • Better understand the role obesity plays in a range of eye disease
  • Consider proposed modifications to examination and management protocols to incorporate known ocular complications associated with obesity
  • Better understand how to utilise incidence and prevalence values in clinical practice
  • Develop confidence in assessing  myopic patients prior to potential cataract surgery
  • Understand appropriate refractive targets, surgical methods and intraocular lens choices for myopic patients based on individual patient characteristics
  • Recognise the relationship between myopia and glaucoma
  • Understand the diagnostic challenges faced when both coexist
  • Discuss the new tools to aid in the diagnosis and management
  • Describe the impacts of the most important systemic autoimmune cause of blindness
  • Describe the impacts of the most important systemic autoinflammatory causes of blindness
  • Recognise when eye inflammation is autoimmune versus autoinflammatory versus infective
  • Understand when to initiate and maintain management or refer appropriately
  • Understand when to use which steroids and when to avoid them
  • Understand and manage microbes - to kill, control or nurture
  • Understand why the optometrist has an important role in routine care for people living with dementia and/or Parkinson’s Disease
  • Understand how dementia and Parkinson’s Disease can impact ocular motility and binocular function, and what to look for during the routine eye examination
  • Understand the relationship between cognitive impairment associated with dementia, eye care access inequities and poor visual outcomes
  • Learn ways to modify management of common age-related eye diseases to accommodate cognitive impairment
  • Understand the tips and tricks to better counsel and manage patients with trifocal IOLs pre- and post-operatively in order to improve patient outcomes and satisfaction

Max CPD hours awarded: UP TO 22 (12T)

Session Information

Name
Opening Keynote Address: AI, data and eye care
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Eyes on our lifestyle: the impact of our daily habits on ocular surface health
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Don’t leave your patients high and dry! Targeted topical and oral therapeutics for dry eye disease
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Zap, squeeze, scrub, scrape and drape! Effective management strategies for dry eye disease
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
How will climate change affect the ocular surface?
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

Ultra® One Day – Go Beyond with the Most Complete

Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name

Astigmats and the Upgrade Conundrum

Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

The PERSPECTIVE real-world study: Insights for the Australian setting

Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Staying in control of progressing myopia
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Near work and myopia: The divergent opinions regarding binocular vision and accommodation errors in myopia
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Review of Myopia Control with Rodenstock
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
When they slip through the cracks: assessment and management of pathological myopia
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Magic growth curves to predict myopia development, are we there yet?
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

The Benefits of Integrated Imaging Software in Optometry Practice

Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Plenary Session: CXO Presents: Public health and Indigenous eye health: Optometry needs to do more
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

Ultra® Monthlies – Comfort, Vision & Eye Health

Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
As far as the eye can see - new contact lens technologies
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
The effects of contact lenses on the binocular vision system
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

Maximizing patient retention in optometry practices: Leveraging product and business model innovation

Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
An arm’s length look at contact lens options for presbyopia
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
C is for Compliance, but A is for Adherence: Helping contact lens wearers score an A
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
What we’ve learned and what questions remain after the 7-year MiSight® 1 day clinical trial
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Beyond chemo-fog: Ocular complications from anticancer drugs
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Obesity and eye disease: What weight should it place on your clinical examination?
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

Cataract surgery in myopes - management tips and pitfalls for optometrists & Glaucoma and Myopia – Challenges in diagnosis and management

Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

Systemic autoimmune disease and eye health. Not quite what you expected?

Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Looking after the eyes to look after the brain: Neurodegenerative diseases and eye health
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name

Optometrists & trifocal IOLs – Improving outcomes through collaboration

Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1.5

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.